Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Dyslipidemia

  Free Subscription


Articles published in Curr Opin Lipidol

Retrieve available abstracts of 52 articles:
HTML format



Single Articles


    April 2020
  1. BRANDTS J, Dharmayat KI, Ray KK, Vallejo-Vaz AJ, et al
    Familial hypercholesterolemia: is it time to separate monogenic from polygenic familial hypercholesterolemia?
    Curr Opin Lipidol. 2020 Apr 22. doi: 10.1097/MOL.0000000000000675.
    PubMed     Abstract available


  2. BAJAJ A, Cuchel M
    Homozygous familial hypercholesterolemia: what treatments are on the horizon?
    Curr Opin Lipidol. 2020 Apr 22. doi: 10.1097/MOL.0000000000000677.
    PubMed     Abstract available


    January 2020
  3. D'ERASMO L, Di Costanzo A, Arca M
    Autosomal recessive hypercholesterolemia: update for 2020.
    Curr Opin Lipidol. 2020 Jan 31. doi: 10.1097/MOL.0000000000000664.
    PubMed     Abstract available


    December 2019
  4. HOLVEN KB, Ulven SM, Bogsrud MP
    Editorial Comment: Hyperlipidaemia and cardiovascular disease and impact of early cholesterol accumulation.
    Curr Opin Lipidol. 2019;30:490-493.
    PubMed    


    August 2019
  5. TADA H, Nohara A, Kawashiri MA
    Monogenic, polygenic, and oligogenic familial hypercholesterolemia.
    Curr Opin Lipidol. 2019;30:300-306.
    PubMed     Abstract available


    June 2019
  6. SORAN H, Ho JH, Adam S, Durrington PN, et al
    Non-HDL cholesterol should not generally replace LDL cholesterol in the management of hyperlipidaemia.
    Curr Opin Lipidol. 2019 Jun 18. doi: 10.1097/MOL.0000000000000614.
    PubMed     Abstract available


  7. BURKHARDT R
    Hyperlipidemia and cardiovascular disease: new insights on lipoprotein(a).
    Curr Opin Lipidol. 2019;30:260-261.
    PubMed    


    May 2019
  8. HUET F, Roubille C, Roubille F
    Is hypertriglyceridemia atherogenic?
    Curr Opin Lipidol. 2019 May 27. doi: 10.1097/MOL.0000000000000622.
    PubMed     Abstract available


    April 2019
  9. ALVES AC, Chora JR, Bourbon M
    Genomics of familial hypercholesterolaemia.
    Curr Opin Lipidol. 2019;30:148-150.
    PubMed    


    February 2019
  10. PEREZ-MATOS MC, Sandhu B, Bonder A, Jiang ZG, et al
    Lipoprotein metabolism in liver diseases.
    Curr Opin Lipidol. 2019;30:30-36.
    PubMed     Abstract available


    January 2019
  11. AWAN ZA, Bondagji NS, Bamimore MA
    Recently reported familial hypercholesterolemia-related mutations from cases in the Middle East and North Africa region.
    Curr Opin Lipidol. 2019 Jan 28. doi: 10.1097/MOL.0000000000000586.
    PubMed     Abstract available


  12. MINAME MH, Bittencourt MS, Nasir K, Santos RD, et al
    Subclinical coronary atherosclerosis and cardiovascular risk stratification in heterozygous familial hypercholesterolemia patients undergoing statin treatment.
    Curr Opin Lipidol. 2019 Jan 14. doi: 10.1097/MOL.0000000000000573.
    PubMed     Abstract available


  13. TOMLINSON B, Hu M, Chow E
    Current status of familial hypercholesterolemia in Chinese populations.
    Curr Opin Lipidol. 2019 Jan 14. doi: 10.1097/MOL.0000000000000580.
    PubMed     Abstract available


    December 2018
  14. MATA P, Alonso R, Perez de Isla L
    Atherosclerotic cardiovascular disease risk assessment in familial hypercholesterolemia: does one size fit all?
    Curr Opin Lipidol. 2018;29:445-452.
    PubMed     Abstract available


    June 2018
  15. TIETGE UJF
    PURE and simple? A new perspective on the impact of diet on hyperlipidemia and cardiovascular risk.
    Curr Opin Lipidol. 2018;29:273-274.
    PubMed    


    April 2018
  16. PAQUETTE M, Baass A
    Predicting cardiovascular disease in familial hypercholesterolemia.
    Curr Opin Lipidol. 2018 Apr 26. doi: 10.1097/MOL.0000000000000519.
    PubMed     Abstract available


    January 2018
  17. RABES JP, Beliard S, Carrie A
    Familial hypercholesterolemia: experience from France.
    Curr Opin Lipidol. 2018 Jan 31. doi: 10.1097/MOL.0000000000000496.
    PubMed     Abstract available


  18. SMYTH N, Ramsay M, Raal FJ
    Population specific genetic heterogeneity of familial hypercholesterolemia in South Africa.
    Curr Opin Lipidol. 2018 Jan 24. doi: 10.1097/MOL.0000000000000488.
    PubMed     Abstract available


  19. VOLTA A, Hovingh GK, Grefhorst A
    Genetics of familial hypercholesterolemia: a tool for development of novel lipid lowering pharmaceuticals?
    Curr Opin Lipidol. 2018 Jan 19. doi: 10.1097/MOL.0000000000000489.
    PubMed     Abstract available


  20. PAQUETTE M, Genest J, Baass A
    Familial hypercholesterolemia: experience from the French-Canadian population.
    Curr Opin Lipidol. 2018 Jan 19. doi: 10.1097/MOL.0000000000000487.
    PubMed     Abstract available


    October 2017
  21. HOLVEN KB, Ulven SM, Bogsrud MP
    Hyperlipidemia and cardiovascular disease with focus on familial hypercholesterolemia.
    Curr Opin Lipidol. 2017;28:445-447.
    PubMed    


    August 2017
  22. NEMES K, Aberg F
    Interpreting lipoproteins in nonalcoholic fatty liver disease.
    Curr Opin Lipidol. 2017;28:355-360.
    PubMed     Abstract available


    July 2017
  23. BADIMON L, Padro T, Cubedo J
    Protein changes in non-LDL-lipoproteins in familial hypercholesterolemia: implications in cardiovascular disease manifestation and outcome.
    Curr Opin Lipidol. 2017 Jul 5. doi: 10.1097/MOL.0000000000000441.
    PubMed     Abstract available


    June 2017
  24. PAALVAST Y, de Boer JF, Groen AK
    Developments in intestinal cholesterol transport and triglyceride absorption.
    Curr Opin Lipidol. 2017;28:248-254.
    PubMed     Abstract available


    April 2017
  25. GRAHAM CA, Latten MJ, Hart PJ
    Molecular diagnosis of familial hypercholesterolaemia.
    Curr Opin Lipidol. 2017 Apr 29. doi: 10.1097/MOL.0000000000000430.
    PubMed     Abstract available


  26. MARTIN AC, Bell DA, Brett T, Watts GF, et al
    Beyond cascade screening: detection of familial hypercholesterolaemia at childhood immunization and other strategies.
    Curr Opin Lipidol. 2017 Apr 19. doi: 10.1097/MOL.0000000000000423.
    PubMed     Abstract available


  27. BURKE AC, Huff MW
    ATP-citrate lyase: genetics, molecular biology and therapeutic target for dyslipidemia.
    Curr Opin Lipidol. 2017;28:193-200.
    PubMed     Abstract available


  28. ARSENAULT BJ, Perrot N, Couture P
    Does lifestyle contribute to disease severity in patients with inherited lipid disorders?
    Curr Opin Lipidol. 2017;28:177-185.
    PubMed     Abstract available


  29. ROTONDO D, Davidson J
    Gene therapy, a promising treatment for familial hypercholesterolaemia.
    Curr Opin Lipidol. 2017;28:216-217.
    PubMed    


    March 2017
  30. CALANDRA S, Tarugi P, Bertolini S
    Impact of rare variants in autosomal dominant hypercholesterolemia causing genes.
    Curr Opin Lipidol. 2017 Mar 18. doi: 10.1097/MOL.0000000000000414.
    PubMed     Abstract available


    February 2017
  31. KINDT I, Mata P, Knowles JW
    The role of registries and genetic databases in familial hypercholesterolemia.
    Curr Opin Lipidol. 2017 Feb 6. doi: 10.1097/MOL.0000000000000398.
    PubMed     Abstract available


  32. BOURBON M, Alves AC, Sijbrands EJ
    Low-density lipoprotein receptor mutational analysis in diagnosis of familial hypercholesterolemia.
    Curr Opin Lipidol. 2017 Feb 6. doi: 10.1097/MOL.0000000000000404.
    PubMed     Abstract available


  33. HOPKINS PN, Lane SR
    Genotype-guided diagnosis in familial hypercholesterolemia: clinical management and concerns.
    Curr Opin Lipidol. 2017 Feb 2. doi: 10.1097/MOL.0000000000000397.
    PubMed     Abstract available


  34. TAHER J, Farr S, Adeli K
    Central nervous system regulation of hepatic lipid and lipoprotein metabolism.
    Curr Opin Lipidol. 2017;28:32-38.
    PubMed     Abstract available


  35. BJORNSON E, Adiels M, Taskinen MR, Boren J, et al
    Kinetics of plasma triglycerides in abdominal obesity.
    Curr Opin Lipidol. 2017;28:11-18.
    PubMed     Abstract available


    January 2017
  36. SANTOS RD
    Phenotype vs. genotype in severe familial hypercholesterolemia: what matters most for the clinician?
    Curr Opin Lipidol. 2017 Jan 5. doi: 10.1097/MOL.0000000000000391.
    PubMed     Abstract available


    December 2016
  37. HOPKINS PN
    Genotype-guided diagnosis in familial hypercholesterolemia: population burden and cascade screening.
    Curr Opin Lipidol. 2016 Dec 24. doi: 10.1097/MOL.0000000000000388.
    PubMed     Abstract available


  38. NORMAN R, Watts GF, Weintraub W, Gidding SS, et al
    Challenges in the health economics of familial hypercholesterolemia.
    Curr Opin Lipidol. 2016;27:563-569.
    PubMed     Abstract available


  39. KOCKX M, Kritharides L
    Hyperlipidaemia in immunosuppression.
    Curr Opin Lipidol. 2016;27:631-632.
    PubMed    


    August 2016
  40. HARALAMBOS K, Ashfield-Watt P, McDowell IF
    Diagnostic scoring for familial hypercholesterolaemia in practice.
    Curr Opin Lipidol. 2016;27:367-374.
    PubMed     Abstract available


    April 2016
  41. GENCER B, Nanchen D
    Identifying familial hypercholesterolemia in acute coronary syndrome.
    Curr Opin Lipidol. 2016.
    PubMed     Abstract available


  42. BOGSRUD MP, Ulven SM, Holven KB
    Does intrauterine exposure to hypercholesterolemia adversely affect familial hypercholesterolemia phenotype?
    Curr Opin Lipidol. 2016.
    PubMed     Abstract available


  43. MUNDAL L, Retterstol K
    A systematic review of current studies in patients with familial hypercholesterolemia by use of national familial hypercholesterolemia registries.
    Curr Opin Lipidol. 2016.
    PubMed     Abstract available


  44. HIGGINS CA, Rees A
    Do the mechanisms by which LDL-c levels are reduced influence the extent of clinical benefit which subsequently accrues?
    Curr Opin Lipidol. 2016;27:207-8.
    PubMed    


  45. STENDER S, Tybjaerg-Hansen A
    Using human genetics to predict the effects and side-effects of drugs.
    Curr Opin Lipidol. 2016;27:105-11.
    PubMed     Abstract available


  46. GHAZALPOUR A, Cespedes I, Bennett BJ, Allayee H, et al
    Expanding role of gut microbiota in lipid metabolism.
    Curr Opin Lipidol. 2016;27:141-7.
    PubMed     Abstract available


  47. GAUDET D
    Novel therapies for severe dyslipidemia originating from human genetics.
    Curr Opin Lipidol. 2016;27:112-24.
    PubMed     Abstract available


    February 2016
  48. FARR S, Taher J, Adeli K
    Central nervous system regulation of intestinal lipid and lipoprotein metabolism.
    Curr Opin Lipidol. 2016;27:1-7.
    PubMed     Abstract available


    December 2015
  49. BRAHM AJ, Hegele RA
    Combined hyperlipidemia: familial but not (usually) monogenic.
    Curr Opin Lipidol. 2015.
    PubMed     Abstract available


  50. SIJBRANDS EJ, Nieman K, Budoff MJ
    Cardiac computed tomography imaging in familial hypercholesterolaemia: implications for therapy and clinical trials.
    Curr Opin Lipidol. 2015;26:586-92.
    PubMed     Abstract available


  51. GRYN SE, Hegele RA
    Novel therapeutics in hypertriglyceridemia.
    Curr Opin Lipidol. 2015;26:484-91.
    PubMed     Abstract available


  52. WIERZBICKI AS, Watts GF
    The hinterland of familial hypercholesterolaemia: what do we not know?
    Curr Opin Lipidol. 2015;26:475-83.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Dyslipidemia is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: